MDxHealth’s (MDXH) Neutral Rating Reiterated at BTIG Research
BTIG Research restated their neutral rating on shares of MDxHealth (NASDAQ:MDXH – Free Report) in a report released on Monday, MarketBeat.com reports. Several other equities analysts have also recently weighed in on the company. Weiss Ratings cut MDxHealth from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, September […]
22 Oct 05:24 · The Markets Daily